Objective To predict the potential target and pharmacological mechanism of Yinqiao Powder (YQP) in the treatment of influenza. MethodsThe symptom mapping (SymMap) platform was retrieved to obtain the targets of all herbs in YQP. Influenza-related targets were obtained using the Comparative Toxicogenomics Database (CTD) and DisgeNet database. The String database was used to construct the protein-protein interaction (PPI) network; the Metascape platform was used to enrich key targets by GeneOntology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. Data were visualized and analyzed using software such as Bioinformatics, Edrawmax, and Cytoscape. Results A total of 263 potential targets of YQP for influenza treatment were screened. There are 256 nodes and 3697 edges in the PPI network. The key targets of the PPI network are AKT1, TP53, INS, IL6, MAPK3, VEGFA, etc. The results of Go enrichment showed that YQP can interfere with biological processes such as response to toxic substance, cytokine-mediated signaling pathway, response to lipopolysaccharide, response to extracellular stimulus, and positive regulation of cell death. The results of KEGG pathway enrichment showed that YQP could interfere with the infection process of the influenza virus by intervening PI3K/Akt, TNF, IL-17, MAPK, and other pathways. Conclusion This study reflects the multi-target and multi-pathway action characteristics of Yinqiaosan, and its mechanism of action in the treatment of influenza may be related to the regulation of PI3K-Akt, NF-kappa B, and MAPK signaling pathways. However, further experimental studies are needed to verify the specific mechanism of YQP.